Diabetes control and complications in private primary healthcare in Malaysia

Medical Journal of Malaysia

Volumn 60, Issue 2, 2005, Pages 212-217

  Mafauzy, Mohamed ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Diabetes care; Diabetes complications; Dyslipidaemia; Glycaemic control; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALBUMINURIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; EXERCISE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MICROALBUMINURIA; NEUROPATHY; PRIMARY HEALTH CARE; PRIVATE HOSPITAL; RETINOPATHY; TRIACYLGLYCEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PRIVATE PRACTICE; RANDOMIZED CONTROLLED TRIAL; URBAN POPULATION;

DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIVATE PRACTICE; URBAN POPULATION;

EID: 24944574446     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. M Mafauzy, N Mokhtar, WB Wan Mohamad, M. Musalmah. Diabetes mellitus and associated cardiovascular risk factors in North East Malaysia. Asia Pacific Journal of Public Health 1999; 11(1): 16-19.
2. Pillay PR, Lim EH. Incidence of diabetes mellitus in Malaya. Medical Journal Malaya 1960; 16: 242-44.
3. Tchobroutsky G. Relation of diabetic control to development of microvascular complications. Diabetologia 1978; 15: 143-52.
4. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978; 1: 168-88.
5. P Relchard, B. Berglund, A. Britz, I. Cars, BY Nilsson, U Rosenqvist. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM); The Stockholm Diabetes Intervention Study (SDIS) after 5 years. Journal of Internal Medicine 1991; 230: 101-3.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
7. Mustaffa BE, Wan Mohamad WB, Chan SP, Rokiah P, Mafauzy M, Kumari S. The current status of diabetes management in Malaysia. The Journal of the ASEAN Federation of Endocrine Societies 1998; 16(2): 1-13.
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 2001; 24(Supplement 1): S33-S43.
9. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabetic Medicine 1999; 16: 716-30.
10. Asia-Pacific Type 2 Diabetes Policy Group. Type 2 Diabetes - Practical targets and treatments. Health Communication Australia Pty Limited, Sydney, Australia; 2002, Third Edition.
11. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). British Medical Journal 1998; 317: 703-13.
12. Eid M, Mafauzy M, Faridah AR. Glycaemic control of type 2 diabetic patients on follow up at Hospital Universiti Sains Malaysia. Malaysian Journal of Medical Sciences 2003; 10(2): 40-49.
13. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care. 1997; 20: 614-20.
14. Goldberg RG, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, Davis BR. Cardiovascular events and their reduction with pravastatin in diabetes and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analysis in the Cholesterol and Recurrent Events (CARE) Trial. Circulation 1998; 98: 2513-19.